Idiopathic pulmonary fibrosis (IPF) represents a particularly aggressive disease, the aetiology
of which still remains unknown. The natural history of the disease often leads to respiratory …

… Comparison of interferon γ-1b (IFN-) and colchicines in the treatment of idiopathic
pulmonary fibrosis: preliminary results of a prospective, multicenter randomized study. Paper …

… A preliminary study of long-term treatment with interferon γ-1b and low-dose prednisolone
in patients with idiopathic pulmonary fibrosis … Interferon-γ1b for pulmonary fibrosis …

… To conclude, this small series of idiopathic pulmonary fibrosis cases treated with … this
treatment improves pulmonary function or alters the natural course of idiopathic pulmonary fibrosis. …

… Idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia is a deadly disease with no
effective treatment… prednisone in the treatment of idiopathic pulmonary fibrosis: a randomised …

… idiopathic pulmonary fibrosis (IPF) and the efficacy and safety of interferon gamma-1b (IFNγ−1b)
in its treatment… colchicine in the treatment of idiopathic pulmonary fibrosis: interim results …

… interpret new data on the treatment of idiopathic pulmonary fibrosis with caution 16. This is
… safe treatment regimen is determined through clinical trials for idiopathic pulmonary fibrosis. …

… of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis. …
of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis. …

… Idiopathic pulmonary fibrosis (IPF) is a progressive and invariably fatal disease with a
median … This trial of the TH 1 cytokine interferon-γ1b, although ultimately negative, proved an …

… The dose was selected based on the findings of the idiopathic pulmonary fibrosis trials and
doses of IFN-1b used in the treatment of chronic granulomatous disease. It is unlikely that …